Cardiac sympathetic denervation to prevent life-threatening arrhythmias

Nature Reviews Cardiology

Volumn 11, Issue 6, 2014, Pages 346-353

  Schwartz, Peter J ^a  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; OXPRENOLOL; PLACEBO;

ADRENERGIC RECEPTOR BLOCKING; ADRENERGIC SYSTEM; ANALGESIA; ANGINA PECTORIS; ANTIARRHYTHMIC ACTIVITY; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CHANNELOPATHY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OCCLUSION; EFFERENT NERVE; EXTRASYSTOLE; FAINTNESS; FOLLOW UP; FUNCTIONAL DISEASE; HEART ARREST; HEART ARRHYTHMIA; HEART DENERVATION; HEART FAILURE; HEART INFARCTION; HEART INNERVATION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART RATE; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE CONTRACTILITY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE PERFORMANCE; HEART VENTRICLE TACHYCARDIA; HORNER SYNDROME; HUMAN; INCIDENCE; ISCHEMIC CARDIOMYOPATHY; LEFT CARDIAC SYMPATHETIC DENERVATION; LONG QT SYNDROME; MULTICENTER STUDY (TOPIC); NONHUMAN; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; PROGNOSIS; QT INTERVAL; QT PROLONGATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REINNERVATION; REVIEW; STELLATE GANGLION; STELLATE GANGLION BLOCK; SUDDEN CARDIAC DEATH; SUDDEN DEATH; SUPERSENSITIVITY; SYMPATHECTOMY; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE; SYMPATHETIC TONE; SYMPATHETIC TRUNK; T WAVE; VAGUS NERVE STIMULATION; VAGUS REFLEX; VAGUS TONE; WARMING;

ARRHYTHMIAS, CARDIAC; ELECTROCARDIOGRAPHY; HEART; HUMANS; SYMPATHECTOMY; TREATMENT OUTCOME;

EID: 84901498008     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2014.19     Document Type: Review

References (77)

1. Lown, B. Sudden cardiac death: the major challenge confronting contemporary cardiology. Am. J. Cardiol. 43, 313-320 (1979).
2. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian Gambit: A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Eur. Heart J. 12, 1112-1131 (1991).
3. Leriche, R., Herman, L. & Fontaine, R. Ligature de la coronaire gauche et fonction du coeur après énervation sympathique [French]. C. R. Soc. Biol. 107, 547-548 (1931).
4. Cox, W. V., Lewiston, M. E. & Robertson, H. F. The effect of stellate ganglionectomy on the cardiac function of intact dogs: And its effect on the extent of myocardial infarction and on cardiac function following coronary artery occlusion. Am. Heart J. 12, 285-300 (1936).
5. Schauer, G., Gross, L. & Blum, L. Hemodynamic studies in experimental coronary occlusion: IV. Stellate ganglionectomy experiments. Am. Heart J. 14, 669-676 (1937).
6. McEachern, C. G., Manning, G. W. & Hall, G. E. Sudden occlusion of coronary arteries following removal of cardiosensory pathways: An experimental study. Arch. Intern. Med. 65, 661-670 (1940).
7. Harris, A. S., Estandia, A. & Tillotson, R. F. Ventricular ectopic rhythms and ventricular fibrillation following cardiac sympathectomy and coronary occlusion. Am. J. Physiol. 165, 505-512 (1951).
8. Milch, E. et al. Experimental prevention of sudden death from acute coronary artery occlusion in the dog. Am. Heart J. 50, 483-491 (1955).
9. Skelton, R. B., Gergely, N., Manning, G. W. & Coles, J. C. Mortality studies in experimental coronary occlusion. J. Thorac. Cardiovasc. Surg. 44, 90-96 (1962).
10. Schaal, S. F., Wallace, A. G. & Sealy, W. C. Protective influence of cardiac denervation against arrhythmias of myocardial infarction. Cardiovasc. Res. 3, 241-244 (1969).
11. Ebert, P. A., Vanderbeek, R. B., Allgood, R. J. & Sabiston, D. C. Jr. Effect of chronic cardiac denervation on arrhythmias after coronary artery ligation. Cardiovasc. Res. 4, 141-147 (1970).
12. Fowlis, R. A. F., Sang, C. T. M., Lundy, P. M., Ahuja, S. P. & Colhoun, H. Experimental coronary artery ligation in conscious dogs six months after bilateral cardiac sympathectomy. Am. Heart J. 88, 748-757 (1974).
13. Schwartz, P. J. & Stone, H. L. Left stellectomy in the prevention of ventricular fibrillation caused by acute myocardial ischemia in conscious dogs with anterior myocardial infarction. Circulation 62, 1256-1265 (1980). (Pubitemid 11217194)
14. Schwartz, P. J. Cutting nerves and saving lives. Heart Rhythm 6, 760-763 (2009).
15. Francois-Frank, C. A. Signification physiologique de la resection du sympathique dans la maladie de Basedow, l'epilepsie, l'idiotic et le glaucoma [French]. Bull. Acad. Méd. Paris 41, 565-594 (1899).
16. Jonnesco, T. Traitement chirurgical de l'angine de poitrine par la résection du sympathique cervico-thoracique [French]. Presse Méd. 20, 221-230 (1921).
17. Danielopolu, D. Le traitement chirurgical de l'angine de poitrine à la lumière des dernières recherches cliniques et expérimentales [French]. C. R. Soc. Bio. Tome I 92, 1157 (1925).
18. Reid, M. R. & Dewitt Andrus, W. The surgical treatment of angina pectoris. Ann. Surg. 81, 591-604 (1925).
19. Leriche, R. & Fontaine, R. Rôle du ganglion étoile gauche dans le déterminisme de la crise de l'angine de poitrine [French]. C. R. Acad. Sci. 188, 279-280 (1929).
20. Danielopolu, D. L'infarctus du myocarde accident de la stellectomie dans l'angine de poitrine [French]. Presse Méd. 56, 337-338 (1948).
21. Lindgren, I. & Olivecrona, H. Surgical treatment of angina pectoris. J. Neurosurg. 4, 19-39 (1947).
22. Burnett, C. F. & Evans, J. A. Follow-up report on resection of the anginal pathway in thirty-three patients. JAMA 162, 709-712 (1956).
23. Cox, W. V. Influence of stellate ganglion block on angina pectoris and the post-exercise ECG. Am. J. Med. 252, 289-295 (1966).
24. Estes, E. H. Jr & Izlar, H. R. Jr. Recurrent ventricular tachycardia: A case successfully treated by bilateral cardiac sympathectomy. Am. J. Med. 31, 493-497 (1961).
25. Zipes, D. P. et al. Treatment of ventricular arrhythmia by permanent atrial pacemaker and cardiac sympathectomy. Ann. Intern. Med. 68, 591-597 (1968).
26. Moss, A. J. & McDonald, J. Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome. N. Engl. J. Med. 285, 903-904 (1971).
27. Yanowitz, F., Preston, J. B. & Abildskov, J. A. Functional distribution of right and left stellate innervation to the ventricles: Production of neurogenic electrocardiographic changes by unilateral alteration of sympathetic tone. Circ. Res. 18, 416-428 (1966).
28. Schwartz, P. J., Periti, M. & Malliani, A. The long QT syndrome. Am. Heart J. 89, 378-390 (1975).
29. Schwartz, P. J. & Malliani, A. Electrical alternation of the T wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long QT syndrome Am. Heart J. 89, 45-50 (1975).
30. Schwartz, P. J. Idiopathic long QT syndrome: Progress and questions. Am. Heart J. 109, 399-411 (1985). (Pubitemid 16248481)
31. Schwartz, P. J. The rationale and the role of left stellectomy for the prevention of malignant arrhythmias. Ann. N. Y. Acad. Sci. 427, 199-221 (1984).
32. Schwartz, P. J. in Nervous Control of Cardiovascular Function Ch. 10 (ed. Randall, W. C.) 225-252 (Oxford University Press, 1984).
33. Schwartz, P. J. & Priori, S. G. in Cardiac Electrophysiology: From Cell to Bedside 1st edn Ch. 37 (eds Zipes, D. P. & Jalife, J.) 330-343 (Saunders, 1990).
34. Schwartz, P. J., Stone, H. L. & Brown, A. M. Effects of unilateral stellate ganglion blockade on the arrhythmias associated with coronary occlusion. Am. Heart J. 92, 589-599 (1976).
35. Schwartz, P. J., Billman, G. E. & Stone. H. L. Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction: An experimental preparation for sudden cardiac death. Circulation 69, 790-800 (1984). (Pubitemid 14125661)
36. Schwartz, P. J., Snebold, N. G. & Brown, A. M. Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold. Am. J. Cardiol. 37, 1034-1040 (1976).
37. Odero, A., Bozzani, A., De Ferrari, G. M. & Schwartz, P. J. Left cardiac sympathetic denervation for the prevention of life-threatening arrhythmias. The surgical supraclavicular approach to cervico-thoracic sympathectomy. Heart Rhythm 7, 1161-1165 (2010).
38. Harris, A. S., Otero, H. & Bocage, A. J. The induction of arrhythmias by sympathetic activity before and after occlusion of a coronary artery in the canine heart. J. Electrocardiol. 4, 34-43 (1971).
39. Schwartz, P. J. & Vanoli, E. Cardiac arrhythmias elicited by interaction between acute myocardial ischemia and sympathetic hyperactivity: A new experimental model for the study of antiarrhythmic drugs. J. Cardiovasc. Pharmacol. 3, 1251-1259 (1981). (Pubitemid 12235109)
40. Schwartz, P. J., Vanoli, E., Zaza, A. & Zuanetti, G. The effect of antiarrhythmic drugs on life-threatening arrhythmias induced by the interaction between acute myocardial ischemia and sympathetic hyperactivity. Am. Heart J. 109, 937-948 (1985). (Pubitemid 15053250)
41. Schwartz, P. J. & Stone, H. L. Effects of unilateral stellectomy upon cardiac performance during exercise in dogs. Circ. Res. 44, 637-645 (1979). (Pubitemid 9177069)
42. Cannon, W. B. A law of denervation. Am. J. Med. Sci. 198, 737-750 (1939).
43. Goodall, M. & Kirshner, N. Effect of cervico-thoracic ganglionectomy on the adrenaline and noradrenaline content in the mammalian heart. J. Clin. lnvest. 35, 649-656 (1956).
44. Hertting, G. & Schlefthaler, T. H. The effect of stellate ganglion excision on the catecholamine content and the uptake of 3H-norepinephrine in the heart of the cat. lnt. J. Neuropharmacol. 3, 65-69 (1964).
45. Schwartz, P. J. & Stone, H. L. Left stellectomy and denervation supersensitivity in conscious dogs. Am. J. Cardiol. 49, 1185-1190 (1982). (Pubitemid 12059074)
46. Randall, W. C. & Rohse, W. G. The augmentor action of the sympathetic cardiac nerves. Circ. Res. 4, 470-475 (1956).
47. Schwartz, P. J., Verrier, R. L. & Lown, B. Effect of stellectomy and vagotomy on ventricular refractoriness. Circ. Res. 40, 536-540 (1977). (Pubitemid 8122478)
48. Cerati, D. & Schwartz, P. J. Single cardiac vagal fibers activity, acute myocardial ischemia, and risk for sudden death. Circ. Res. 69, 1389-1401 (1991).
49. Malliani, A., Recordati, G. & Schwartz, P. J. Nervous activity of afferent cardiac sympathetic fibres with atrial and ventricular endings. J. Physiol. 229, 457-469 (1973).
50. Schwartz, P. J., Pagani, M., Lombardi, F., Malliani, A. & Brown, A. M. A cardio-cardiac sympatho-vagal reflex in the cat. Circ. Res. 32, 215-220 (1973).
51. Schwartz, P. J. Autonomic modulation for chronic heart failure: A new kid on the block? Eur. J. Heart Fail. 14, 1316-1318 (2012).
52. De Ferrari, G. M. & Schwartz, P. J. Left cardiac sympathetic denervation in patients with heart failure: A new indication for an old intervention? J. Cardiovasc. Trans. Res. http://dx. doi. org/10. 1007/s12265-014-9541-0.
53. Schwartz, P. J. et al. Long term vagal stimulation in patients with advanced heart failure: first experience in man. Eur. J. Heart Fail. 10, 884-891 (2008).
54. De Ferrari, G. M. et al. Chronic vagus nerve stimulation: A new and promising therapeutic approach for chronic heart failure. Eur. Heart J. 32, 847-855 (2011).
55. Schwartz, P. J. & De Ferrari, G. M. Sympathetic-parasympathetic interaction in health and disease: Abnormalities and relevance in heart failure. Heart Fail. Rev. 16, 101-107 (2011).
56. Billman, G. E., Schwartz, P. J. & Stone, H. L. Baroreceptor reflex control of heart rate: A predictor of sudden cardiac death. Circulation 66, 874-880 (1982). (Pubitemid 12015075)
57. Schwartz, P. J. et al. Autonomic mechanisms and sudden death: new insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 78, 969-979 (1988).
58. La Rovere, M. T. et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 351, 478-484 (1998). (Pubitemid 28070094)
59. La Rovere, M. T. et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: Implications for clinical trials. Circulation 103, 2072-2077 (2001). (Pubitemid 32373010)
60. Vanoli, E. et al. Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ. Res. 68, 1471-1481 (1991).
61. Billman, G. E. Cardiac autonomic neural remodeling and susceptibility to sudden cardiac death: Effect of endurance exercise training. Am. J. Physiol. Heart Circ. Physiol. 297, H1171-H1193 (2009).
62. Schwartz, P. J. et al. Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome: A worldwide report. Circulation 84, 503-511 (1991).
63. Schwartz, P. J. et al. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long QT syndrome. Circulation 109, 1826-1833 (2004). (Pubitemid 38509115)
64. Collura, C. A., Johnson, J. N., Moir, C. & Ackerman, M. J. Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery. Heart Rhythm 6, 752-759 (2009).
65. Coleman, M. A. et al. Videoscopic left cardiac sympathetic denervation for patients with recurrent ventricular fibrillation/malignant ventricular arrhythmia syndromes besides congenital long QT syndrome. Circ. Arrhythm. Electrophysiol. 5, 782-788 (2012).
66. Schwartz, P. J. & Ackerman, M. J. The long QT syndrome: A transatlantic clinical approach to diagnosis and therapy. Eur. Heart J. 34, 3109-3116 (2013).
67. Schwartz, P. J. Efficacy of left cardiac sympathetic denervation has an unforeseen side effect: medicolegal complications. Heart Rhythm 7, 1330-1332 (2010).
68. Wilde, A. A. M. et al. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N. Engl. J. Med. 358, 2024-2029 (2008). (Pubitemid 351656456)
69. Roses-Noguer, F., Jarman, J. W., Clague, J. R. & Till, J. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 11, 58-66 (2014).
70. Atallah, J. et al. Video-assisted thorascopic cardiac denervation: A potential novel therapeutic option for children with intractable ventricular arrhythmias. Ann. Thorac. Surg. 86, 1620-1625 (2008).
71. Schwartz, P. J. et al. Effect of ventricular fibrillation complicating acute myocardial infarction on long term prognosis: Importance of the site of infarction. Am. J. Cardiol. 56, 384-389 (1985). (Pubitemid 15238048)
72. Schwartz, P. J. et al. Prevention of sudden cardiac death after a first myocardial infarction by pharmacologic or surgical antiadrenergic interventions. J. Cardiovasc. Electrophysiol. 3, 2-16 (1992).
73. Bourke, T. et al. Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation. Circulation 121, 2255-2262 (2010).
74. Ajijola, O. A. et al. Bilateral cardiac sympathetic denervation for the management of electrical storm. J. Am. Coll. Cardiol. 59, 91-92 (2012).
75. Vaseghi, M. et al. Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: Intermediate and long-term follow-up. Heart Rhythm 11, 360-366 (2014).
76. Boogers, M. J. et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J. Am. Coll. Cardiol. 55, 2769-2777 (2010).
77. Watanabe, H. et al. Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 10, 542-547 (2013).